Hematology

I-Mab Biopharma announces dosing of first patient in mainland China with TJ202/MOR202 for multiple myeloma

The EMA accepts regulatory submission for Lumoxiti in relapsed or refractory hairy cell leukemia

WuXi Biologics applauds OncoImmune over FDA clearance of IND application for ONC-392

Researchers have created a new discovery model for mantle cell lymphoma

Antibody-drug conjugate for breast cancer gets good marks in HER2CLIMB top-line analysis

A look at gastroesophageal, gastric and colorectal cancer progress, as well as other recent news of oncology research breakthroughs

Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials

Toca 5 Phase 3 trial results presented at the Society for Neuro-Oncology annual meeting

Duke launches center to explore innovative science and technology policy

Taiho Oncology reports promising findings for patients with prior gastrectomy

Phase 2 trial evaluates a new tool in pediatric cancer immunotherapy

Ivy Brain Tumor Center and Salarius conduct preclinical study to test seclidemstat